Latest Breaking News On - Unaudited full year - Page 1 : comparemela.com

JBT Corporation Announces Intention to Launch a Voluntary Takeover Offer to Effectuate Merger with Marel hf; also Announces Solid Preliminary 2023 Financial Results and 2024 Guidance

Key Highlights: Full year 2023 preliminary earnings per share in excess of guidance driven by strong operational execution; a discrete tax benefit of approximately $0.33 per share favorably.

United statesBrian deckSecurities exchangeMarel corporationExchange commissionUs securities exchangeCompany investor relationsFinancial supervisory authority of the central bankGoldman sachs coKirkland ellisChief executiveInvestor relationsUnaudited full yearContinuing operationsStrategic rationaleChief executive officer

JBT Corp (JBT) to Launch a Voluntary Takeover Offer to Effectuate Merger with Marel hf, Reports Prelim FY23 and FY24 Guidance

JBT Corp (JBT) to Launch a Voluntary Takeover Offer to Effectuate Merger with Marel hf, Reports Prelim FY23 and FY24 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrian deckJbt corporationCompany investor relationsMarel corporationFinancial supervisory authority of the central bankChief executiveInvestor relationsUnaudited full yearContinuing operationsStrategic rationaleChief executive officerNasdaq icelandFinancial supervisory authorityCentral bankIcelandic takeovers act

Rapid Micro Biosystems Announces Preliminary Unaudited

Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth.

United statesSamsung biologicsCompany growthSecurities exchangeCompany annual report on formRapid micro biosystems incExchange commissionHealthcare conferenceMicro biosystemsFourth quarterPreliminary unaudited revenueGrowth directUnaudited full yearRapid micro biosystemsGrowth direct systemSecurities act

Rapid Micro Biosystems (RPID) Reports Prelim Q4 and 2023 Revenue

Rapid Micro Biosystems (RPID) Reports Prelim Q4 and 2023 Revenue
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Samsung biologicsRapid micro biosystems incRapid micro biosystemsFourth quarterPreliminary unaudited revenueGrowth directUnaudited full year

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

Full-Year Total Revenue Expected to be Approximately $197.5 Million, Representing 20% Growth, with Fourth Quarter Revenue Growth of 23% to $65 Million MACI Full-Year Revenue Expected to be.

United kingdomUnited statesEric burnsNick colangeloVericel corporationExchange commissionMediwound ltdFull year total revenue expectedFourth quarter revenue growthYear revenue expectedQuarter burn care revenue growthUnaudited full yearUnaudited fourth quarter financial resultsOperating cash flowHealthcare conferenceInvestor relations